FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study

(2022) Jiyun Park et al.   Cardiovascular Diabetology

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study

(2022) Zhewen Ren et al.   HEPATOLOGY

Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus

(2022) I. Mikolasevic et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis

(2022) Ying Xi et al.   Cell Metabolism

Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study

(2021) Giovanni Tarantino et al.   Journal of Clinical Medicine

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD

(2021) Lorena Pantano et al.   Scientific Reports

Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers

(2021) Zhenqiu Liu et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study

(2020) Jun Hyung Kim et al.   Cardiovascular Diabetology

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation

(2020) Jamie Bates et al.   JOURNAL OF HEPATOLOGY

FSTL3 induces lipid accumulation and inflammatory response in macrophages and associates with atherosclerosis

(2019) Ma Runhua et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

(2019) Dong Hyun Sinn et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD

(2019) Stergios A Polyzos et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Liver fibrosis by FibroScan ® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

(2019) Rosa Lombardi et al.   LIVER INTERNATIONAL

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

(2016) Sven M. Francque et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice

(2015) Claus Brandt et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

(2014) Katherine R. Tuttle et al.   DIABETES CARE

Inhibition of the mTOR pathway: A possible protective role in coronary artery disease

(2013) Giovanni Tarantino et al.   ANNALS OF MEDICINE

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   CIRCULATION

Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease

(2011) W. Nseir et al.   DIGESTIVE DISEASES AND SCIENCES

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

(2011) V. W.-S. Wong et al.   GUT

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury

(2009) Yuichi Oshima et al.   CIRCULATION